Global Glaucoma Treatment Market to grow with 4.81% CAGR during 2018-2023

November 15, 2019


According to the research report titled ‘Global Glaucoma Treatment Market: Analysis By Indication, By Drug Class, By Sales Channel, By Region, By Country (2018 Edition): Forecast to 2023 - By Indication (Open Angle, Closed Angle, Secondary, Congenital, Others), By Drug Class (Prostaglandin Analogs, Beta Blockers, Alpha Agonist, Carbonic Anhydrase Inhibitors)’ available with Market Study Report LLC, the global glaucoma treatment market is estimated to grow with a CAGR of 4.81% during the period of 2018-2023.
 

Glaucoma is an eye-related disorder wherein damage to optic nerve can lead to impaired vision or even blindness. High pressure in eye is main the cause of this ailment. Increasing cases of glaucoma, in consort with easy accessibility of drugs across pharmacies and rising number of healthcare facilities are augmenting the growth of glaucoma treatment market.
 

By indication, glaucoma treatment market is divided into congenital, secondary, open angle, closed angles and others. While based on sales channel, the market is bifurcated into retail pharmacy, hospital pharmacy and others.
 

As per drug class, glaucoma treatment market is segmented into prostaglandin analogs, alpha agonist, beta blockers, carbonic anhydrase inhibitors, and others, wherein the foremost segment is presumed to witness momentous growth over the forecast period, cites the report.
 

Considering the geographical landscape, the global glaucoma treatment market is fragmented into regions namely, Europe, North America, Asia Pacific, and rest of the world, with a key focus on countries like Canada, Germany, UK, US, Japan, India, China, and Brazil. The report cites that North America held the largest regional share in glaucoma treatment market in 2018, due to favorable federal reforms, robust development in healthcare segment, and growing occurrences of glaucoma across the region.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/1357062/
 

The key players of glaucoma treatment market are Pfizer, Allergan, Novartis, Ocular Therapeutix, Teva Pharmaceuticals and Aerie Pharmaceuticals.
 

Notably, the research report discusses and examines the potential growth opportunities in global glaucoma treatment market. It also provides crucial statistics on revenue shares for each segment.  The study further aims to deliver top-notch business information and help investors to evaluate their investments thoroughly.


Frequently Asked Questions (FAQ) :

Increasing cases of glaucoma, in consort with easy accessibility of drugs across pharmacies and rising number of healthcare facilities are augmenting the growth of glaucoma treatment market.
By indication, glaucoma treatment market is divided into congenital, secondary, open angle, closed angle, and others. As per drug class, the market is segmented into prostaglandin analogs, alpha agonist, beta blockers, carbonic anhydrase inhibitors, and others. While, based on sales channel, the industry is bifurcated as hospital pharmacy, retail pharmacy and others.
North American glaucoma treatment market held the largest regional share in 2018, due to favorable federal reforms, robust development in healthcare segment, and growing occurrences of glaucoma across the region.
The key players of glaucoma treatment market are Pfizer, Allergan, Novartis, Ocular Therapeutix, Teva Pharmaceuticals and Aerie Pharmaceuticals.